Dithiocarbazate–Zn(ii) complexes for photodynamic therapy and chemotherapy against lung cancer

文献信息

发布日期 2023-09-20
DOI 10.1039/D3QI01777J
影响因子 6.569
作者

JunGang Deng, YouRu Wu, AiLi Li, WeiPing Pan, LiXia Hou, DaQi Wu, ZhenLei Zhang, Feng Yang



摘要

Combining photodynamic therapy with chemotherapy is a promising strategy for treating tumors. Herein, a series of new dithiocarbazate–Zn(II) complexes, including [ZnII(L1)2] Zn1, [ZnII(L2)2] Zn2, [ZnII(L3)2] Zn3, and [ZnII(L4)2] Zn4, have been synthesized for chemotherapy and photodynamic therapy of lung cancer. These complexes can be used for live-cell fluorescence-based imaging, are photostable, and exhibit hemolysis comparable to cisplatin. Among them, complex Zn3 shows good chemotherapeutic ability, and its chemotherapeutic mechanism relies on multiple pathways. At the same time, complex Zn3 generates superoxide anion radicals (˙O2−) under light irradiation, leading to cancer cell death through photodynamic therapy. Its remarkable anticancer effect is achieved through multimodal photodynamic therapy/chemotherapy. This study paves the way for the use of novel Zn(II) complexes as anticancer agents, providing new strategies for multimodal cancer therapy.

来源期刊

Inorganic Chemistry Frontiers

Inorganic Chemistry Frontiers
CiteScore: 10.4
自引率: 6.6%
年发文量: 625

Inorganic Chemistry Frontiers publishes research articles, reviews, notes, comments and methods covering all areas of inorganic chemistry. Emphases are placed on interdisciplinary studies where inorganic chemistry and organometallic chemistry meet related areas, such as catalysis, biochemistry, nanoscience, energy and materials science. For publication in Inorganic Chemistry Frontiers, papers should report high-quality work of exceptional novelty, which will be of significant interest to the wide readership of the journal.

推荐供应商

中国郑州联创食化工贸有限公司
中国四川省申联生物科技有限责任公司
中国安徽鑫龙化工有限公司
中国枣庄瀚邦化工有限公司
中国常州凯康生物科技有限公司
美国格罗顿生物系统公司
中国巩义市强宏镁业科技有限责任公司
德国西门斯建筑技术有限公司
奥地利Waagen Scheffknecht有限公司
中国浙江车头制药有限公司
免责声明
本页面提供的学术期刊信息仅供参考和研究使用。我们与任何期刊出版商均无关联,也不处理投稿事宜。如有投稿相关咨询,请直接联系相关期刊出版商。
如发现页面信息有误,请发送邮件至 [email protected] 联系我们。我们将及时核实并处理您的问题。